Vigabatrin

ATC N03AG04 · 10 markets · 64 records

Vigabatrin 10 markets · 64 records Forms

US 24 records · 7 strengths

  • 500 mgtabletSABRILVIGADRONE、__no_trade__ also in GB·AU·CA +3
  • 500 mgpowderNo trade name also in GB·AU·CA +1
  • 50 mgpowderSABRILvigabatrin for oral solution、VIGADRONE、__no_trade__
  • 500 mgliquidNo trade name also in ES
  • 100 mgliquidVIGAFYDE also in GB
  • 50 mgliquidNo trade name
  • 500 mg/10 mLpowderNo trade name

GB 18 records · 9 strengths

AU 5 records · 3 strengths

  • 500 mgtabletSABRILSABRIL vigabatrin 500mg tablet blister pack also in US·GB·CA +3 unknown
  • 500 mgpowderSABRILSABRIL vigabatrin 0.5g powder oral sachetl also in US·GB·CA +1 unknown

Records without a stated strength · 1 SABRIL

CA 2 records · 2 strengths

ES 2 records · 2 strengths

TW 2 records · 2 strengths

SG 1 records · 1 strengths

HK 1 records · 1 strengths

    Records without a stated strength · 1 SABRIL

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Kigabeq 100mg soluble tablets

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.